US5569469A
(en)
*
|
1984-10-16 |
1996-10-29 |
Vectorpharma International, S.P.A. |
Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
|
IT1241088B
(it)
*
|
1990-03-27 |
1993-12-29 |
Chiesi Farma Spa |
Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche
|
HU210921B
(en)
*
|
1990-03-28 |
1995-09-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
|
IT1246188B
(it)
*
|
1990-07-27 |
1994-11-16 |
Resa Farma |
Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
|
IT1243745B
(it)
*
|
1990-10-17 |
1994-06-21 |
Vectorpharma Int |
Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
|
US5552160A
(en)
*
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
US5399363A
(en)
*
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
EP0519428B1
(en)
*
|
1991-06-21 |
2000-09-20 |
Takeda Chemical Industries, Ltd. |
Cyclodextrin compositions with fumagillol derivates
|
HUT70952A
(en)
*
|
1992-06-10 |
1995-11-28 |
Eastman Kodak Co |
Surface modified nanoparticles based on nosteroidal inflammatory drugs, process for preparing them and pharmaceutical compns. contg. them
|
IT1255462B
(it)
*
|
1992-07-28 |
1995-11-02 |
Grazia Maffione |
Metodo di preparazione di composti di inclusione di nimesulide con ciclodestrine
|
NZ248813A
(en)
*
|
1992-11-25 |
1995-06-27 |
Eastman Kodak Co |
Polymeric grinding media used in grinding pharmaceutical substances
|
HU213200B
(en)
|
1993-05-12 |
1997-03-28 |
Chinoin Gyogyszer Es Vegyeszet |
The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production
|
GB9316580D0
(en)
*
|
1993-08-10 |
1993-09-29 |
Smithkline Beecham Plc |
Pharmaceutical composition
|
TW384224B
(en)
*
|
1994-05-25 |
2000-03-11 |
Nano Sys Llc |
Method of preparing submicron particles of a therapeutic or diagnostic agent
|
US5684121A
(en)
*
|
1994-12-06 |
1997-11-04 |
Isp Investments Inc. |
N-vinyl lactam polymer containing tablets of low friability and high rate of dissolution
|
US5759577A
(en)
*
|
1995-01-17 |
1998-06-02 |
American Home Products Corporation |
Controlled release of steroids from sugar coatings
|
US5547948A
(en)
*
|
1995-01-17 |
1996-08-20 |
American Home Products Corporation |
Controlled release of steroids from sugar coatings
|
US5518738A
(en)
*
|
1995-02-09 |
1996-05-21 |
Nanosystem L.L.C. |
Nanoparticulate nsaid compositions
|
US5612053A
(en)
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
US6348469B1
(en)
|
1995-04-14 |
2002-02-19 |
Pharma Pass Llc |
Solid compositions containing glipizide and polyethylene oxide
|
PT822808E
(pt)
*
|
1995-04-20 |
2000-12-29 |
Eurand Int |
Composito com glicolato de amido e sodio como material de suporte e produtos seus derivados
|
US20050267302A1
(en)
*
|
1995-12-11 |
2005-12-01 |
G.D. Searle & Co. |
Eplerenone crystalline form exhibiting enhanced dissolution rate
|
US5686133A
(en)
*
|
1996-01-31 |
1997-11-11 |
Port Systems, L.L.C. |
Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
|
HUP9600758A2
(en)
*
|
1996-03-27 |
1998-03-02 |
Cyclolab Ciklodextrin Kutato F |
Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
|
US6048547A
(en)
*
|
1996-04-15 |
2000-04-11 |
Seth; Pawan |
Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient
|
JP2000509374A
(ja)
|
1996-04-19 |
2000-07-25 |
アルファ セラピュティック コーポレイション |
凍結乾燥した血液タンパク質のウイルス不活性化方法
|
FR2757397B1
(fr)
*
|
1996-12-23 |
1999-03-05 |
Mazal Pharma |
Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
US20070141181A1
(en)
|
1998-02-13 |
2007-06-21 |
Nutramax Laboratories, Inc. |
Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
|
US6451771B1
(en)
|
1999-02-12 |
2002-09-17 |
Nutramax Laboratories, Inc. |
Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals
|
US6797289B2
(en)
|
1998-02-13 |
2004-09-28 |
Nutramax Laboratories, Inc. |
Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
|
US6086242A
(en)
*
|
1998-02-27 |
2000-07-11 |
University Of Utah |
Dual drive planetary mill
|
US6197347B1
(en)
|
1998-06-29 |
2001-03-06 |
Andrx Pharmaceuticals, Inc. |
Oral dosage for the controlled release of analgesic
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
FR2786100B1
(fr)
*
|
1998-11-24 |
2002-03-01 |
Aventis Laboratoire |
Nouvelle application therapeutique de la nicergoline
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6264981B1
(en)
*
|
1999-10-27 |
2001-07-24 |
Anesta Corporation |
Oral transmucosal drug dosage using solid solution
|
EP1175434A2
(en)
*
|
1999-12-08 |
2002-01-30 |
Pharmacia Corporation |
Eplerenone crystalline form
|
US20030083493A1
(en)
*
|
1999-12-08 |
2003-05-01 |
Barton Kathleen P. |
Eplerenone drug substance having high phase purity
|
UA74539C2
(en)
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
WO2001041760A2
(en)
*
|
1999-12-08 |
2001-06-14 |
Pharmacia Corporation |
Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
|
US7108866B1
(en)
|
1999-12-10 |
2006-09-19 |
Biovall Laboratories International Srl |
Chronotherapeutic diltiazem formulations and the administration thereof
|
US20060153914A1
(en)
*
|
1999-12-10 |
2006-07-13 |
Biovail Laboratories International S.R.L. |
Chronotherapeutic diltiazem formulations and the administration thereof
|
AR035642A1
(es)
|
2000-05-26 |
2004-06-23 |
Pharmacia Corp |
Uso de una composicion de celecoxib para el alivio rapido del dolor
|
US20020146409A1
(en)
*
|
2001-01-30 |
2002-10-10 |
Herring Steven W. |
Methods for stabilizing lyophilized blood proteins
|
AR034518A1
(es)
|
2001-06-18 |
2004-02-25 |
Noven Pharma |
Incremento en la administracion transdermica de un farmaco
|
KR100759635B1
(ko)
*
|
2001-06-22 |
2007-09-17 |
화이자 프로덕츠 인코포레이티드 |
비정질 약물의 흡착체의 약학 조성물
|
EP1269994A3
(en)
*
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmaceutical compositions comprising drug and concentration-enhancing polymers
|
ATE377413T1
(de)
*
|
2001-06-29 |
2007-11-15 |
Eurand Pharmaceuticals Ltd |
Verfahren für die thermodynamische aktivierung von wasserlöslichen arzneimitteln, die in vernetzten polymeren geladen sind
|
US20030073609A1
(en)
|
2001-06-29 |
2003-04-17 |
Pinkerton Thomas C. |
Enhanced pharmacokinetic profile of intradermally delivered substances
|
WO2003026662A1
(en)
*
|
2001-09-25 |
2003-04-03 |
Pharmacia Corporation |
Solid-state forms of n-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole
|
ATE395044T1
(de)
|
2002-02-01 |
2008-05-15 |
Pfizer Prod Inc |
Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
AU2003230885A1
(en)
*
|
2002-04-12 |
2003-10-27 |
Elan Pharma International Ltd. |
Nanoparticulate megestrol formulations
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
ITMI20021074A1
(it)
*
|
2002-05-20 |
2003-11-20 |
Actimex S R L |
Composizione ternaria comprendente una sostanza attiva e processo di comacinazione per la sua preparazione
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
DE10259640A1
(de)
*
|
2002-12-18 |
2004-07-08 |
Hager & Werken Gmbh & Co Kg |
Einfärbemittel zur Sichtbarmachung von Plaque-Bildung auf Zähnen sowie Verfahren zur Herstellung eines solchen Einfärbemittels
|
US20040132771A1
(en)
*
|
2002-12-20 |
2004-07-08 |
Pfizer Inc |
Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
|
US9498454B2
(en)
|
2003-02-24 |
2016-11-22 |
Pharmaceutical Productions Inc. |
Transmucosal drug delivery system
|
US9254294B2
(en)
|
2003-02-24 |
2016-02-09 |
Pharmaceutical Productions Inc. |
Transmucosal hormone delivery system
|
KR101170844B1
(ko)
|
2003-02-24 |
2012-08-02 |
파마슈티칼 프로덕션스, 인크. |
경점막 약물 전달 시스템
|
US9358296B2
(en)
|
2003-02-24 |
2016-06-07 |
Pharmaceutical Productions Inc. |
Transmucosal drug delivery system
|
US10172810B2
(en)
|
2003-02-24 |
2019-01-08 |
Pharmaceutical Productions, Inc. |
Transmucosal ketamine delivery composition
|
PT1638527E
(pt)
*
|
2003-06-27 |
2007-02-28 |
Bioprogress Spa |
Produto compósito obtido por co-trituração de um princípio activo com um copolímero de n-vinil-2-pirrolidona/acetato de vinilo
|
DK1558582T3
(da)
|
2003-07-22 |
2006-05-08 |
Arena Pharm Inc |
Diaryl og arylheteroarylureaderivater som modulatorer af aktiviteten af 5-HT2A-serotoninreceptoren anvendelige til profylakse eller behandling af forstyrrelser relateret dertil
|
ATE540671T1
(de)
|
2003-08-04 |
2012-01-15 |
Bend Res Inc |
Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien
|
MX2008000396A
(es)
*
|
2005-06-22 |
2009-02-23 |
Elan Pharma Int Ltd |
Formulaciones de megestrol en nanoparticula.
|
CN101410012A
(zh)
*
|
2006-03-28 |
2009-04-15 |
杰佛林制药公司 |
低剂量的非甾体抗炎药和β-环糊精的制剂
|
KR20080112285A
(ko)
|
2006-03-28 |
2008-12-24 |
자블린 파머슈티칼스 인코포레이티드 |
저 복용량의 디클로페낙 및 베타-사이클로덱스트린 제형
|
AU2007264418B2
(en)
*
|
2006-06-30 |
2012-05-03 |
Iceutica Pty Ltd |
Methods for the preparation of biologically active compounds in nanoparticulate form
|
AU2016203251B2
(en)
*
|
2006-06-30 |
2017-11-16 |
Iceutica Pty Ltd |
Methods for the Preparation of Biologically Active Compounds in Nanoparticle Form
|
CL2007002689A1
(es)
|
2006-09-18 |
2008-04-18 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
|
TWI415845B
(zh)
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物
|
WO2009023253A2
(en)
|
2007-08-15 |
2009-02-19 |
Arena Pharmaceuticals Inc. |
IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
|
US8821924B2
(en)
|
2007-09-14 |
2014-09-02 |
Wockhardt Ltd. |
Rhein or diacerein compositions
|
EP2520286A1
(en)
*
|
2007-09-27 |
2012-11-07 |
Wockhardt Limited |
Pharmaceutical compositions of rhein or diacerein
|
US20100285114A1
(en)
*
|
2007-09-27 |
2010-11-11 |
Rahul Dabre |
Pharmaceutical compositions of rhein or diacerein
|
WO2009048940A2
(en)
*
|
2007-10-08 |
2009-04-16 |
Dr. Reddy's Laboratories Ltd. |
Diacerein pharmaceutical formulations
|
US8642062B2
(en)
|
2007-10-31 |
2014-02-04 |
Abbott Cardiovascular Systems Inc. |
Implantable device having a slow dissolving polymer
|
WO2009123714A2
(en)
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
US9126946B2
(en)
|
2008-10-28 |
2015-09-08 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
|
EP2349336B1
(en)
*
|
2008-10-28 |
2017-11-22 |
Agency For Science, Technology And Research |
Mesoporous material excipients for poorly aqueous soluble ingredients
|
DK2364142T3
(en)
|
2008-10-28 |
2018-04-30 |
Arena Pharm Inc |
COMPOSITIONS OF A 5-HT2A SEROTONIN RECEPTOR MODULATOR USED FOR TREATMENT OF DISEASES RELATED TO THE RECEPTOR
|
US7828996B1
(en)
|
2009-03-27 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Method for the manufacture of stable, nano-sized particles
|
AP2015008955A0
(en)
|
2009-04-24 |
2015-12-31 |
Icuetica Pty Ltd |
A novel formulation of indomethacin
|
WO2010148158A1
(en)
*
|
2009-06-17 |
2010-12-23 |
Isp Investments Inc. |
A process for preparation of stable, microencapsulated and sustained release biocidal actives and composition thereof
|
AR077692A1
(es)
|
2009-08-06 |
2011-09-14 |
Vitae Pharmaceuticals Inc |
Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
|
JP5870775B2
(ja)
*
|
2011-05-11 |
2016-03-01 |
ライオン株式会社 |
錠剤及びその製造方法
|
RU2607515C2
(ru)
|
2011-07-22 |
2017-01-10 |
Хемоцентрикс, Инк. |
Кристаллическая форма натриевой соли 4-трет-бутил-n-{ 4-хлор-2-(1-окси-пиридин-4-карбонил)-фенил} -бензолсульфонамид
|
WO2013016156A1
(en)
|
2011-07-22 |
2013-01-31 |
Glaxo Group Limited |
Polymorphic forms of the sodium salt of 4-tert- butyl -n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
|
KR101378951B1
(ko)
*
|
2011-07-29 |
2014-03-31 |
재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 |
생체이용률이 향상된 초산 메게스트롤 분말을 포함하는 경구투여용 제제 및 이의 제조방법
|
WO2013030374A1
(en)
|
2011-09-01 |
2013-03-07 |
Glaxo Group Limited |
Novel crystal form
|
KR20130025851A
(ko)
*
|
2011-09-02 |
2013-03-12 |
재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 |
메게스트롤 속붕해정 및 이의 제조 방법
|
WO2013095318A2
(en)
*
|
2011-12-23 |
2013-06-27 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Orally-disintegrating formulations of flurbiprofen
|
WO2013100881A2
(en)
*
|
2011-12-27 |
2013-07-04 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Combined pharmaceutical formulation containing diacerein
|
ITMI20120092A1
(it)
|
2012-01-26 |
2013-07-27 |
Micro Macinazione S A |
Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia
|
US10835495B2
(en)
|
2012-11-14 |
2020-11-17 |
W. R. Grace & Co.-Conn. |
Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|
WO2015198229A1
(en)
|
2014-06-25 |
2015-12-30 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline salts of (s)-6-((1-acetylpiperidin-4-yl)amino)-n-(3-(3,4-dihydroisoquinolin-2(1h)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide
|
WO2016038519A1
(en)
|
2014-09-08 |
2016-03-17 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-n-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide
|
US10022355B2
(en)
|
2015-06-12 |
2018-07-17 |
Axovant Sciences Gmbh |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder
|
RU2018103338A
(ru)
|
2015-07-15 |
2019-08-15 |
Аксовант Сайенсиз Гмбх |
Производные диарил- и арилгетероарилмочевины для профилактики и лечения галлюцинаций, ассоциированных с нейродегенеративным заболеванием
|